ticagrelor News
Most Popular ticagrelor Story
Brilinta data fuels AZ's hopes for megablockbuster
Scientists for AstraZeneca have pulled the wraps off their head-to-head Phase III trial for the blockbuster clotting drug candidate Brilinta, offering a detailed look at the therapy's improved Read more...
Latest Headlines
- November 17, 2009
- August 31, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
